Comparing in silico flowsheet optimization strategies in biopharmaceutical downstream processes
Biotechnology Progress · 2025-03 · 41 (2)
DOI: 10.1002/btpr.3514 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Biotechnology Progress, online erschienen am 18.10.2024. Verfasst von Daphne Keulen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Delft University of Technology, Delft, The Netherlands. Hauptthemen laut MEDLINE: Computer Simulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: GlaxoSmithKline Biologicals SA, GlaxoSmithKline Biologicals.
Abstract (Originalsprache)
The challenging task of designing biopharmaceutical downstream processes is initially to select the type of unit operations, followed by optimizing their operating conditions. For complex flowsheet optimizations, the strategy becomes crucial in terms of duration and outcome. In this study, we compared three optimization strategies, namely, simultaneous, top‐to‐bottom, and superstructure decomposition. Moreover, all strategies were evaluated by either using chromatographic Mechanistic Models (MMs) or Artificial Neural Networks (ANNs). An overall evaluation of 39 flowsheets was performed, including a buffer‐exchange step between the chromatography operations. All strategies identified orthogonal structures to be optimal, and the weighted overall performance values were generally consistent between the MMs and ANNs. In terms of time‐efficiency, the decomposition method with MMs stands out when utilizing multiple cores on a multiprocessing system for simulations. This study analyses the influence of different optimization strategies on flowsheet optimization and advices on suitable strategies and modeling techniques for specific scenarios.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.
- GSK, Technical Research & Development, Rixensart, Belgium.
ORCID-Profile: Daphne Keulen
Förderung
- GlaxoSmithKline Biologicals SA
- GlaxoSmithKline Biologicals
Zitieren
APA
Keulen, D., Apostolidi, M., Geldhof, G., Le Bussy, O., Pabst, M., & Ottens, M. (2025). Comparing in silico flowsheet optimization strategies in biopharmaceutical downstream processes. Biotechnology Progress, 41(2). https://doi.org/10.1002/btpr.3514
Vancouver
Keulen D, Apostolidi M, Geldhof G, Le Bussy O, Pabst M, Ottens M. Comparing in silico flowsheet optimization strategies in biopharmaceutical downstream processes. Biotechnology Progress. 2025;41(2). doi:10.1002/btpr.3514
BibTeX
@article{Keulen2025,
author = {Keulen, Daphne and Apostolidi, Myrto and Geldhof, Geoffroy and Le Bussy, Olivier and Pabst, Martin and Ottens, Marcel},
title = {Comparing in silico flowsheet optimization strategies in biopharmaceutical downstream processes},
journal = {Biotechnology Progress},
year = {2025},
volume = {41},
number = {2},
doi = {10.1002/btpr.3514}
}
EUVIMED